对丙氧基肉桂酸 | 69033-81-4

• 物质功能分类: 香精与香料 - 合成香料 - 芳香肉桂酸、酯及衍生物
• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 中文名称: 对丙氧基肉桂酸
• 中文别名: 4-丙氧基肉桂酸
• 英文名称: 4-propoxycinnamic acid
• 英文别名: 3-(4-Propoxyphenyl)acrylic acid；(E)-3-(4-propoxyphenyl)prop-2-enoic acid
• CAS: 69033-81-4
• 化学式: C₁₂H₁₄O₃
• mdl: MFCD00995149
• 分子量: 206.241
• InChiKey: WTYNDSOJMSGRQV-VMPITWQZSA-N

物化性质

• 熔点：
  166.0 to 172.0 °C
• 沸点：
  364.8±17.0 °C(Predicted)
• 密度：
  1.132±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2918990090
• 危险性防范说明：
  P264,P302+P352,P304+P340,P305+P351+P338,P332+P313,P337+P313
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温

SDS

4-Propoxycinnamic Acid Revision number: 5
SAFETY DATA SHEET

---

Section 1. IDENTIFICATION
Product name: 4-Propoxycinnamic Acid

Revision number: 5

---

Section 2. HAZARDS IDENTIFICATION
GHS classification
PHYSICAL HAZARDS Not classified
HEALTH HAZARDS
Skin corrosion/irritation Category 2
Category 2A
Serious eye damage/eye irritation
ENVIRONMENTAL HAZARDS Not classified
GHS label elements, including precautionary statements
Pictograms or hazard symbols
Signal word Warning
Hazard statements Causes skin irritation
Causes serious eye irritation
Precautionary statements:
Wash hands thoroughly after handling.
[Prevention]
Wear protective gloves/eye protection/face protection.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses,
[Response]
if present and easy to do. Continue rinsing.
If eye irritation persists: Get medical advice/attention.
IF ON SKIN: Gently wash with plenty of soap and water.
If skin irritation occurs: Get medical advice/attention.
Take off contaminated clothing and wash before reuse.

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Components: 4-Propoxycinnamic Acid
Percent: >95.0%(GC)(T)
CAS Number: 69033-81-4
Synonyms: 3-(4-Propoxyphenyl)acrylic Acid
C12H14O3
Chemical Formula:

---

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
4-Propoxycinnamic Acid

---

Section 4. FIRST AID MEASURES
Skin contact: Remove/Take off immediately all contaminated clothing. Gently wash with plenty of
soap and water. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
A rescuer should wear personal protective equipment, such as rubber gloves and air-
Protection of first-aiders:
tight goggles.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Precautions for firefighters: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, Use personal protective equipment. Keep people away from and upwind of spill/leak.
protective equipment and Entry to non-involved personnel should be controlled around the leakage area by
emergency procedures: roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Sweep dust to collect it into an airtight container, taking care not to disperse it.
containment and cleaning Adhered or collected material should be promptly disposed of, in accordance with
up: appropriate laws and regulations.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Technical measures: Handling is performed in a well ventilated place. Wear suitable protective equipment.
Prevent dispersion of dust. Wash hands and face thoroughly after handling.
Use a local exhaust if dust or aerosol will be generated.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Conditions for safe storage, including any
incompatibilities
Storage conditions: Keep container tightly closed. Store in a cool and dark place.
Store away from incompatible materials such as oxidizing agents.
Packaging material: Comply with laws.

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Engineering controls: Install a closed system or local exhaust as possible so that workers should not be
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Dust respirator. Follow local and national regulations.
Hand protection: Protective gloves.
Safety glasses. A face-shield, if the situation requires.
Eye protection:
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Solid
Crystal- Powder
Form:
Colour: White - Pale yellow
No data available
Odour:
pH: No data available
Melting point/freezing point:168°C
4-Propoxycinnamic Acid

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Boiling point/range: No data available
Flash point: No data available
Flammability or explosive
limits:
Lower: No data available
Upper: No data available
Relative density: No data available
Solubility(ies):
[Water] No data available
No data available
[Other solvents]

---

Section 10. STABILITY AND REACTIVITY
Chemical stability: Stable under proper conditions.
Possibility of hazardous No special reactivity has been reported.
reactions:
Incompatible materials: Oxidizing agents
Hazardous decomposition Carbon monoxide, Carbon dioxide
products:

---

Section 11. TOXICOLOGICAL INFORMATION
No data available
Acute Toxicity:
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
No data available
IARC =
NTP = No data available
No data available
Reproductive toxicity:

---

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobility in soil
Log Pow: No data available
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

---

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system.
Observe all federal, state and local regulations when disposing of the substance.

---

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
UN-No: Not listed
4-Propoxycinnamic Acid

---

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26, 2002
and revised on February 16,2011): Safe use and production, the storage of a dangerous chemical, transport,
loading and unloading were prescribed.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  对丙氧基肉桂酸 在 氯化亚砜 作用下， 生成 4-propoxycinnamic acid
  参考文献：
  名称：

  新型乙烯衍生物的合成及液晶性质

  摘要：

  合成了一系列新型液晶，即α-4-[4'-n-烷氧基肉桂酰氧基]苯甲酰基-β-4″-氯苯基乙烯。该系列由十二个同系物组成。甲基到丁基的衍生物不是液晶，其余的同系物是对映液晶。该系列的辛基至十二烷基衍生物除了具有致线虫的特性外，还具有对映性近晶化，但该系列的戊基、己基、庚基十四烷基和十六烷基同系物仅具有致线虫性，不显示近晶相。新物质的转变温度是通过配备加热台的光学偏光显微镜测定的。转变温度与正烷氧基末端链中存在的碳原子数的关系图代表了该系列的相行为。对于向列-各向同性转变曲线，观察到奇偶效应。向列相的织构为螺纹或纹影型，近晶 A 和近晶 C 相的织构是典型的。分析和光谱数据与分子结构一致。近晶和向列热稳定性分别为 132.6°C 和 156.7°C。近晶相从辛氧基同系物开始。近亲相长度从 26°C 到 33°C 不等，生线虫相长度从 6°C 到 70°C 不等。该系列主要是生线虫，部分是近生的

  DOI：

  10.1080/15421406.2013.781491
• 作为产物：
  描述：

  methyl 4-hydroxycinnamate 在 氢氧化钾 、 sodium hydroxide 、 Aliquat 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 76.0h， 生成 对丙氧基肉桂酸
  参考文献：
  名称：

  肉桂酸衍生的恶唑啉离子作为新型细胞毒性剂。

  摘要：

  取代的肉桂酰氯11被转化为（2-羟乙基）-恶唑啉鎓氯化物14，N，N-双-（2-氯乙基）酰胺16和（2-氯乙基）-恶唑啉鎓氯化物17。尽管衍生物14具有电子-供体取代基（Me或MeO）比被吸电子基团（NO（2），Cl或CF（3））取代的取代基更有效，细胞毒性肌动蛋白的差异不明显。一系列烷氧基取代的衍生物14中亲脂性的修饰导致活性更高的化合物，其中具有4-辛氧基-苯基取代基的14t在microM范围内最有效且显示出细胞毒活性。假定恶唑啉盐起烷基化剂的作用，

  DOI：

  10.1016/s0223-5234(02)01375-2

文献信息

• 一种石蒜碱β-芳基丙烯酸酯衍生物及其制备方法和用途
  申请人：山东达因海洋生物制药股份有限公司

  公开号：CN113416199B

  公开（公告）日：2022-03-01

  本申请提供一种石蒜碱β‑芳基丙烯酸酯衍生物及其制备方法和应用。所述石蒜碱β‑芳基丙烯酸酯衍生物具有式I所示结构：其中，Ar为C6‑12芳烃或C3‑10芳杂环，所述的芳杂环中的杂原子选自N、O、S；R为Ar上的取代基，为单取代或多取代，R独立地选自氢、卤素、卤代C1‑6烷基、卤代C1‑6烷氧基、硝基、羟基、C1‑6烷基、C1‑6烷氧基、C2‑6链烯基氧基、C2‑6烯基、C3‑6环烷基、苯基。所述石蒜碱β‑芳基丙烯酸酯衍生物具有良好的抗肿瘤活性，具有较好的药用前景。
• Non-thiol Farnesyltransferase Inhibitors: Utilization of the Far Aryl Binding Site by 5-Cinnamoylaminobenzophenones
  作者：Andreas Mitsch、Pia Wißner、Markus Böhm、Katrin Silber、Gerhard Klebe、Isabel Sattler、Martin Schlitzer

  DOI：10.1002/ardp.200400871

  日期：2004.9

  We recently described two novel aryl binding sites of farnesyltransferase. In this study, the cinnamoyl residue was designed as an appropriate substituent for our benzophenone‐based AAX‐peptidomimetic compound capable of occupying the far aryl binding site.

  我们最近描述了法呢基转移酶的两个新的芳基结合位点。在这项研究中，肉桂酰基残基被设计为我们基于二苯甲酮的 AAX 肽模拟化合物的合适取代基，能够占据远芳基结合位点。
• Synthesis and biological evaluation of α -santonin derivatives as anti-hepatoma agents
  作者：Hao Chen、Xiao Yang、Zongmin Yu、Ziying Cheng、Hu Yuan、Zeng Zhao、Guozhen Wu、Ning Xie、Xing Yuan、Qingyan Sun、Weidong Zhang

  DOI：10.1016/j.ejmech.2018.02.073

  日期：2018.4

  A series of α-santonin-derived compounds as potentially anti-hepatoma agents were designed and synthesized in an effort to find novel therapeutic agents. Among them, derivative 5h was more potent than the positive control 5-fluorouracil (5-Fu) on HepG-2, QGY-7703 and SMMC-7721 with IC50 values of 7.51, 3.06 and 4.08 μM, respectively. The structure-activity relationships (SARs) of these derivatives

  为了寻找新的治疗剂，设计并合成了一系列α-桑顿蛋白衍生的化合物作为潜在的抗肝癌药物。其中，衍生物5H比阳性对照5-氟尿嘧啶上肝癌HepG-2，QGY-7703（5-FU）和SMMC-7721与IC更有效的50的7.51，3.06和4.08的值 μ分别男，。讨论了这些衍生物的构效关系（SAR）。此外，流式细胞仪和western blot分析表明，该衍生物通过促进凋亡相关蛋白的表达诱导肝癌细胞凋亡。我们的发现表明，这些α素衍生的类似物有望作为治疗人类肝细胞癌的化学治疗剂。
• New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships
  作者：Hisao Nakai、Mitoshi Konno、Shunji Kosuge、Shigeru Sakuyama、Masaaki Toda、Yoshinobu Arai、Takaaki Obata、Nobuo Katsube、Tsumoru Miyamoto

  DOI：10.1021/jm00396a013

  日期：1988.1

  (p-Amylcinnamoyl)anthranilic acid (3a) had moderate antagonist activities against LTD4-induced smooth muscle contraction on guinea pig ileum and LTC4-induced bronchoconstriction in anesthetized guinea pigs. Modifications were made in the hydrophobic part (cinnamoyl moiety) and the hydrophilic part (anthranilate moiety) of 3a. A series of 8-(benzoylamino)-2-tetrazol-5-yl-1,4-benzodioxans and 8-(ben

  （p-戊基肉桂酰基）邻氨基苯甲酸（3a）对LTD4-诱导的豚鼠回肠平滑肌收缩和LTC4诱导的豚鼠支气管收缩具有中等程度的拮抗活性。对3a的疏水部分（肉桂酰基部分）和亲水部分（邻氨基苯甲酸酯部分）进行了修饰。揭示了一系列的8-（苯甲酰基氨基）-2-四唑-5-基-1，4-苯并二恶烷和8-（苯甲酰基氨基）-2-四唑-5-基-4-氧代-4H-1-苯并吡喃。白三烯C4和D4的有效拮抗剂。在这两个系列中，ONO-RS-347（18k）和ONO-RS-411（19h）分别是最有效和口服活性的拮抗剂。讨论了构效关系。
• Discovery of Potent Small-Molecule Inhibitors of Ubiquitin-Conjugating Enzyme UbcH5c from α-Santonin Derivatives
  作者：Hao Chen、Guozhen Wu、Shuang Gao、Ruihua Guo、Zeng Zhao、Hu Yuan、Shanxiang Liu、Jian Wu、Xiaolong Lu、Xing Yuan、Zongmin Yu、Xianpeng Zu、Ning Xie、Niao Yang、Zhenlin Hu、Qingyan Sun、Weidong Zhang

  DOI：10.1021/acs.jmedchem.6b01829

  日期：2017.8.24

  inactivated UbcH5c by forming a covalent adduct with its active site Cys85. Furthermore, compound 6d exhibited potent anti-inflammatory activity against complete Freund’s adjuvant-induced adjuvant arthritis in vivo. These findings suggest that the novel α-santonin-derived UbcH5c inhibitor 6d is a promising lead compound for the development of new antirheumatoid arthritis (RA) agent.

  作为抗肿瘤坏死因子（TNF）-α干预的治疗靶标，UbcH5c是在TNF-α触发的核因子kappa B（NF-κB）激活过程中催化泛素化的关键泛素结合酶之一。在本研究中，从α-桑顿蛋白设计并合成了三个系列类似物，并通过Western印迹和NF-κB荧光素酶法筛选了它们的UbcH5c抑制活性。进一步的BIAcore，凝胶内荧光成像和免疫沉淀分析表明，化合物6d对UbcH5c表现出强大而特异性的抑制作用，超过了阳性化合物1（IJ-5）的抑制作用。机理研究表明，化合物6d通过与其活性位点Cys85形成共价加合物，优先结合UbcH5c并使其失活。此外，化合物6d在体内对完全弗氏佐剂诱导的佐剂关节炎表现出有效的抗炎活性。这些发现表明，新颖的α-桑顿蛋白衍生的UbcH5c抑制剂6d是开发新型抗类风湿关节炎（RA）药物的有前途的先导化合物。